BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value: $469M (92.8% shares, 7.2% debt)

Holdings (34)

— BLUEPRINT MEDICINES CORP 12.5%

Value $58.63M Shares 2,895,251 Est. Cost — Unrealized —

CYTK CYTOKINETICS INC 10.1%

Value $47.35M Shares 4,989,218 Est. Cost — Unrealized —

— CHEMOCENTRYX INC 7.8%

Value $36.74M Shares 8,182,052 Est. Cost — Unrealized —

— EXELIXIS INC 7.2%

Value $33.94M Shares 22,822,778 Est. Cost — Unrealized —

— CONCERT PHARMACEUTICALS INC 6.6%

Value $30.94M Shares 2,755,318 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 6.3%

Value $29.41M Shares 8,260,897 Est. Cost — Unrealized —

— FORWARD PHARMA A/S 5.5%

Value $25.89M Shares 1,424,611 Est. Cost — Unrealized —

IONS IONIS PHARMACEUTICALS INC 4.2%

Value $19.8M Shares 850,000 Est. Cost — Unrealized —

— GLYCOMIMETICS INC 3.8%

Value $17.79M Shares 2,447,415 Est. Cost — Unrealized —

— CASCADIAN THERAPEUTICS INC 3.8%

Value $17.73M Shares 18,799,368 Est. Cost — Unrealized —

— ONCOMED PHARMACEUTICALS INC 3.5%

Value $16.49M Shares 1,339,336 Est. Cost — Unrealized —

— TOBIRA THERAPEUTICS INC 3.4%

Value $15.74M Shares 1,253,401 Est. Cost — Unrealized —

— CTI BIOPHARMA CORP 3.2%

Value $15.23M Shares 44,796,940 Est. Cost — Unrealized —

— ARQULE INC 3.0%

Value $14.15M Shares 7,450,128 Est. Cost — Unrealized —

XENE XENON PHARMACEUTICALS INC 2.2%

Value $10.51M Shares 1,775,572 Est. Cost — Unrealized —

— NIVALIS THERAPEUTICS INC 1.9%

Value $8.862M Shares 1,926,443 Est. Cost — Unrealized —

— VITAE PHARMACEUTICALS INC 1.7%

Value $8.212M Shares 761,079 Est. Cost — Unrealized —

— PARATEK PHARMACEUTICALS INC 1.7%

Value $7.998M Shares 575,000 Est. Cost — Unrealized —

INFIQ INFINITY PHARMACEUTICALS INC 1.5%

Value $6.896M Shares 5,184,600 Est. Cost — Unrealized —

— GTX INC DEL 1.3%

Value $6.332M Shares 11,512,000 Est. Cost — Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.3%

Value $6.192M Shares 606,138 Est. Cost — Unrealized —

— ADURO BIOTECH INC 1.2%

Value $5.809M Shares 513,603 Est. Cost — Unrealized —

MGNX MACROGENICS INC 1.2%

Value $5.398M Shares 200,000 Est. Cost — Unrealized —

ESPR ESPERION THERAPEUTICS INC NE 1.1%

Value $4.932M Shares 499,142 Est. Cost — Unrealized —

— PAIN THERAPEUTICS INC 1.0%

Value $4.708M Shares 2,149,913 Est. Cost — Unrealized —

— QLT INC 0.7%

Value $3.203M Shares 2,255,476 Est. Cost — Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.6%

Value $2.636M Shares 4,813,294 Est. Cost — Unrealized —

— OREXIGEN THERAPEUTICS INC 0.5%

Value $2.258M Shares 5,252,100 Est. Cost — Unrealized —

— MAST THERAPEUTICS INC 0.4%

Value $1.738M Shares 3,696,961 Est. Cost — Unrealized —

— CATALYST BIOSCIENCES INC 0.3%

Value $1.476M Shares 970,948 Est. Cost — Unrealized —

GBIM GLOBEIMMUNE INC 0.3%

Value $1.276M Shares 657,653 Est. Cost — Unrealized —

— CALITHERA BIOSCIENCES INC 0.1%

Value $450K Shares 121,400 Est. Cost — Unrealized —

— PIERIS PHARMACEUTICALS INC 0.1%

Value $389K Shares 241,352 Est. Cost — Unrealized —

— AVIRAGEN THERAPEUTICS INC 0.1%

Value $292K Shares 208,353 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	2,895,251	$58.63M	12.5%	—	—	COM	09627Y109
CYTK	CYTOKINETICS INC	4,989,218	$47.35M	10.1%	—	—	COM NEW	23282W605
—	CHEMOCENTRYX INC	8,182,052	$36.74M	7.8%	—	—	COM	16383L106
—	EXELIXIS INC	22,822,778	$33.94M	7.2%	—	—	NOTE 4.250% 8/1	30161QAC8
—	CONCERT PHARMACEUTICALS INC	2,755,318	$30.94M	6.6%	—	—	COM	206022105
—	ARRAY BIOPHARMA INC	8,260,897	$29.41M	6.3%	—	—	COM	04269X105
—	FORWARD PHARMA A/S	1,424,611	$25.89M	5.5%	—	—	SPONSORED ADR	34986J105
IONS	IONIS PHARMACEUTICALS INC	850,000	$19.8M	4.2%	—	—	COM	462222100
—	GLYCOMIMETICS INC	2,447,415	$17.79M	3.8%	—	—	COM	38000Q102
—	CASCADIAN THERAPEUTICS INC	18,799,368	$17.73M	3.8%	—	—	COM	14740B101
—	ONCOMED PHARMACEUTICALS INC	1,339,336	$16.49M	3.5%	—	—	COM	68234X102
—	TOBIRA THERAPEUTICS INC	1,253,401	$15.74M	3.4%	—	—	COM	88883P101
—	CTI BIOPHARMA CORP	44,796,940	$15.23M	3.2%	—	—	COM	12648L106
—	ARQULE INC	7,450,128	$14.15M	3.0%	—	—	COM	04269E107
XENE	XENON PHARMACEUTICALS INC	1,775,572	$10.51M	2.2%	—	—	COM	98420N105
—	NIVALIS THERAPEUTICS INC	1,926,443	$8.862M	1.9%	—	—	COM	65481J109
—	VITAE PHARMACEUTICALS INC	761,079	$8.212M	1.7%	—	—	COM	92847N103
—	PARATEK PHARMACEUTICALS INC	575,000	$7.998M	1.7%	—	—	COM	699374302
INFIQ	INFINITY PHARMACEUTICALS INC	5,184,600	$6.896M	1.5%	—	—	COM	45665G303
—	GTX INC DEL	11,512,000	$6.332M	1.3%	—	—	COM	40052B108
CTMX	CYTOMX THERAPEUTICS INC	606,138	$6.192M	1.3%	—	—	COM	23284F105
—	ADURO BIOTECH INC	513,603	$5.809M	1.2%	—	—	COM	00739L101
MGNX	MACROGENICS INC	200,000	$5.398M	1.2%	—	—	COM	556099109
ESPR	ESPERION THERAPEUTICS INC NE	499,142	$4.932M	1.1%	—	—	COM	29664W105
—	PAIN THERAPEUTICS INC	2,149,913	$4.708M	1.0%	—	—	COM	69562K100
—	QLT INC	2,255,476	$3.203M	0.7%	—	—	COM	746927102
—	SUNESIS PHARMACEUTICALS INC	4,813,294	$2.636M	0.6%	—	—	COM NEW	867328601
—	OREXIGEN THERAPEUTICS INC	5,252,100	$2.258M	0.5%	—	—	COM	686164104
—	MAST THERAPEUTICS INC	3,696,961	$1.738M	0.4%	—	—	COM	576314108
—	CATALYST BIOSCIENCES INC	970,948	$1.476M	0.3%	—	—	COM	14888D109
GBIM	GLOBEIMMUNE INC	657,653	$1.276M	0.3%	—	—	COM	37957B100
—	CALITHERA BIOSCIENCES INC	121,400	$450K	0.1%	—	—	COM	13089P101
—	PIERIS PHARMACEUTICALS INC	241,352	$389K	0.1%	—	—	COM	720795103
—	AVIRAGEN THERAPEUTICS INC	208,353	$292K	0.1%	—	—	COM	053761102